Overview
Overview
A phase I/IIa clinical trial of HIV-1 vaccines pSG2.HIVconsv DNA, MVA.HIVconsv and Ad35-GRIN in combined regimens in healthy HIV-1/2-negative adults in Nairobi
Sponser
Sponser
EDCTP
Abstract
Abstract
This was a Phase I/IIa randomized, placebo-controlled, double-blind clinical trial in HIV-uninfected healthy adult male and female volunteers aged 18-50 years at low-risk for HIV infection to evaluate the safety, tolerability and immunogenicity of three different candidate HIV vaccines
